Tang Oi Shan, Ho Pak Chung
Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong, SAR, China.
Gynecol Endocrinol. 2006 Dec;22(12):655-9. doi: 10.1080/09513590601005946.
Mifepristone is a progesterone antagonist that has been studied for a number of clinical applications. It is a well-known abortifacient that is effective for both first- and second-trimester medical abortion when used with a prostaglandin analog. It is also an effective cervical priming agent that can be used to soften the cervix before surgical evacuation. Its clinical efficacy as an emergency contraception has been proven. Other applications including treatment for fibroids, endometriosis and various cancers have been explored. However, its association with abortion limits the applications of mifepristone in many of these areas.
米非司酮是一种孕激素拮抗剂,已针对多种临床应用进行了研究。它是一种广为人知的堕胎药,与前列腺素类似物合用时,对孕早期和孕中期的药物流产均有效。它也是一种有效的宫颈预处理剂,可用于在手术清宫前软化宫颈。其作为紧急避孕药的临床疗效已得到证实。还探索了其他应用,包括治疗子宫肌瘤、子宫内膜异位症和各种癌症。然而,它与堕胎的关联限制了米非司酮在许多这些领域的应用。